Investments - Celularity - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule Of Equity Method Investments [Line Items]
Common stock, shares outstanding (in shares)	522,817,137	314,573,225
Celularity
Schedule Of Equity Method Investments [Line Items]
Unrealized losses on marketable investments	$ (63.9)	$ (39.8)
Class A Common Stock | Celularity
Schedule Of Equity Method Investments [Line Items]
Common stock, shares outstanding (in shares)	20,422,124	20,422,124